Titlebook: Biomarkers in Diabetes; Vinood B. Patel,Victor R. Preedy Living reference work 20220th edition Type 2 Diabetes.insulin action.glycaemic m

只看該作者 · 發(fā)表于 2025-3-24 08:30:44

Day-by-Day Home Blood Pressure Monitoring as a Biomarker in Diabetes,have been associated with target organ damage and cardiovascular disease (CVD) risk independent of office blood pressure (OBP). Although hypertension is an important risk factor for diabetic kidney disease (DKD), data are sparse regarding the association between HBP or HBPV and DKD. The J-HOP study

只看該作者 · 發(fā)表于 2025-3-24 14:10:57

Engulfment and Cell Motility Protein (ELMO)-1 as a Biomarker in Type II Diabetes,o monitoring the progression of DN know has been challenging due to its ability to detect early renal lesions, monitoring the progression of renal lesion and treatment to prevent ESRD. Discover novel biomarker performed recently to focus on finding ideal marker of a cellular process that can reflect

只看該作者 · 發(fā)表于 2025-3-24 17:36:25

只看該作者 · 發(fā)表于 2025-3-24 19:17:53

只看該作者 · 發(fā)表于 2025-3-25 00:04:54

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 07:34
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved